<p></p><ul><li><span style="font-family:Arial, Helvetica, sans-serif;font-size:medium;">Lucky Core Industries (LCI) held its corporate briefing
today to discuss FY24 financial result and future outlook.</span></li></ul><ul><li><span style="font-family:Arial, Helvetica, sans-serif;font-size:medium;">Regarding the pharmaceutical business, management
communicated 65% of current portfolio is non-essential. After addition of
Pfizer portfolio the non-essential component will increase by approx. 10% since
majority of the Pfizer brands are non-essential.</span></li></ul><ul><li><span style="font-family:Arial, Helvetica, sans-serif;font-size:medium;">Pfizer's acquisition is expected to conclude in two months,
i.e., October 2024, and the Competition Commission of Pakistan has already
approved it. Company acquired 7 brands of Pfizer.</span></l...
